SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing strong upward momentum as investors pivot toward its QNX division's role in the growing physical AI and robotics sectors, with community sentiment fueled by bullish sentiment regarding new federal certifications and institutional buying. The stock is currently trending on the back of massive volume and excitement surrounding upcoming robotics conference presentations, as shareholders express high conviction in the company's long-term software pivot.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler stock is experiencing a sharp sell-off following a guidance update that revealed a projected deceleration in revenue growth, overshadowing a solid earnings beat. Community sentiment is deeply divided as investors debate whether the 30% drop is a major buying opportunity for a long-term AI cybersecurity leader or a structural reassessment of the company's growth trajectory and sales execution.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending as the community scrutinizes the enterprise software sector's resilience against AI, with traders heavily debating whether recent stock weakness offers a deep-value buying opportunity or a signal of broader structural decline. Investors are fixated on the upcoming earnings report as a critical 'redemption test' that could trigger a sector-wide rotation back into software if management proves that their AI agents and enterprise workflows are delivering tangible growth.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing heightened investor interest and upward momentum driven by strong institutional backing and a major stake acquisition by AMD, highlighting its critical role in AI infrastructure. The community is actively debating the stock's valuation, weighing its rapid ascent against potential long-term benefits of the AI networking and custom silicon buildout as earnings approach.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to significant sector-wide momentum sparked by government investment in quantum infrastructure, though the companys omission from direct federal funding has sparked intense debate among traders. The community is actively split between bulls anticipating a potential short squeeze fueled by high short interest and skeptics questioning the stock's valuation relative to its peers.

Digital Turbine, Inc. is a mobile growth platform that offers solutions for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The firm operates through the On Device Solutions (ODS) and App Growth Platform (AGP) segments. The ODS segment generates revenue from the delivery of mobile application media or content to end users with solutions for all participants in the mobile application ecosystem that want to connect with end users and consumers who hold the device. This includes mobile carriers and device OEMs that participate in the app economy, app publishers and developers, and brands and advertising agencies. The AGP segment provides platforms that allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine is experiencing significant market interest following a string of bullish partnerships, including a deepened integration with Google Cloud and a strategic deal with Orange to scale mobile app distribution. The community is actively debating a potential re-rating of the stock as investors look to upcoming earnings for confirmation that these catalysts are driving a genuine financial turnaround.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant momentum as investors anticipate upcoming satellite launches and react to Europes push to favor regional satellite operators over competitors. The community remains highly active, debating the stock's long-term valuation versus its rapid price appreciation, with heavy institutional buying fueling speculation of a potential short squeeze.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is trending as investors aggressively trade the stock on high volume, fueled by intense speculation regarding its potential exposure to the upcoming SpaceX IPO. While some in the community are rallying behind its aerospace initiatives and defense contracts, others remain highly skeptical due to the company's historical financial performance and the volatility associated with its recent capital-raising announcements.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific stock is facing significant downward pressure as investors react to a downward revision in full-year guidance and concerns over competitive dynamics within the electrophysiology sector. While some market participants are calling the steep pullback an overreaction and eyeing entry points, community discourse remains split between those positioning for a long-term rebound and others bracing for further volatility following the guidance cut.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending as investors react to a wave of institutional developments, including its integration into tokenized financial infrastructure and the launch of futures contracts. While some in the community remain skeptical due to past price performance, many are actively discussing potential upside from the upcoming Clarity Act and ongoing institutional adoption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Capricor Therapeutics Q1 2026 Earnings Call Transcript

Capricor Therapeutics Says NS Pharma Delays Could Threaten Access To Duchenne Therapy

Capricor sued Nippon Shinyaku over Deramiocel distribution terms, citing pricing issues and patient access risks.read more...

Nasdaq, S&P 500 Futures Rise Ahead Of Jobs Report As Iran Ceasefire Holds: Why NVDA, IREN, CRWV, RKLB, UPWK, CAPR Are In Focus

Equity

Data from Stocktwits shows that retail traders’ sentiment has remained ‘bullish’ on SPY and QQQ this week.


CAPR Stock Sinks After-Hours: Capricor Launches Legal Fight Over DMD Therapy Rollout Ahead Of FDA Review

Capricor is seeking court approval to pursue an alternative commercialization path for Deramiocel and wants parts of the agreement terminated.

Capricor Therapeutics (CAPR) Projected to Post Earnings on Tuesday

Capricor Therapeutics (NASDAQ:CAPR) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at...

Oppenheimer & Co. Inc. Cuts Stock Holdings in Capricor Therapeutics, Inc. $CAPR

Oppenheimer & Co. Inc. trimmed its position in shares of Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) by 40.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 80,813 shares of the biotechnology company's stock after selling 54,600 s...

Capricor Therapeutics (NASDAQ:CAPR) Shares Up 7.1% - Still a Buy?

Capricor Therapeutics (NASDAQ:CAPR) Trading 7.1% Higher - What's Next...

CAPR Stock In Focus: Ex-Exec Eyed For FDA Role Says Drug Approvals Are Not ‘Best-In-Class’ Signals

Former Capricor executive Houman David Hemmati said FDA approval should be viewed as a “building permit,” not proof a drug is the best option.

Capricor Therapeutics (NASDAQ:CAPR) Stock Price Down 6.5%  - What's Next?

Capricor Therapeutics (NASDAQ:CAPR) Stock Price Down 6.5% - Should You Sell...

Moody Aldrich Partners LLC Takes Position in Capricor Therapeutics, Inc. $CAPR

Moody Aldrich Partners LLC purchased a new stake in Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 208,755 shares of the biotechnology compan...

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.59	--	--	N/A
Q1 '26	-$0.51	-$0.59	-16.26%	MISSED
Q4 '25	-$0.51	-$0.62	-21.81%	MISSED
Q3 '25	-$0.55	-$0.54	1.22%	BEAT
Q2 '25	-$0.48	-$0.57	-19.75%	MISSED

CAPR
Capricor Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest CAPR News

CAPRCapricor Therapeutics Inc